about
Dopamine D2 receptor activation leads to an up-regulation of glial cell line-derived neurotrophic factor via Gβγ-Erk1/2-dependent induction of Zif268Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug targetRecent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders.Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administrationGlial modulators as potential treatments of psychostimulant abuseTargeted delivery of GDNF through the blood-brain barrier by MRI-guided focused ultrasound.The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.Role of BDNF and GDNF in drug reward and relapse: a reviewCabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor.Increasing the specificity of neurotrophic factors.Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.Endogenous GDNF in ventral tegmental area and nucleus accumbens does not play a role in the incubation of heroin cravingGlial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seekingRole of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving.Alcohol reward, dopamine depletion, and GDNF.Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumptionEthanol and nicotine interaction within the posterior ventral tegmental area in male and female alcohol-preferring rats: evidence of synergy and differential gene activation in the nucleus accumbens shellGDNF is a novel ethanol-responsive gene in the VTA: implications for the development and persistence of excessive drinking.Simultaneous Detection of Both GDNF and GFRα1 Expression Patterns in the Mouse Central Nervous System.GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence.Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stressSignaling pathways mediating alcohol effects.Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses.How toxic is ibogaine?Update of neurotrophic factors in neurobiology of addiction and future directions.Glial cell line-derived neurotrophic factor (GDNF) is an endogenous protector in the mesolimbic system against excessive alcohol consumption and relapse.NCAM signaling mediates the effects of GDNF on chronic morphine-induced neuroadaptations.Impact of Pitx3 gene knockdown on glial cell line-derived neurotrophic factor transcriptional activity in dopaminergic neurons.Dose-Dependent Effects of Binge-Like Methamphetamine Dosing on Dopamine and Neurotrophin Levels in Rat Brain.Neonatal levels of neurotrophic factors and risk of autism spectrum disorders.Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.Short-term ethanol exposure causes imbalanced neurotrophic factor allocation in the basal forebrain cholinergic system: a novel insight into understanding the initial processes of alcohol addiction.
P2860
Q24312888-6852FAD4-F615-45FC-9BBF-EF1920FE0432Q26798948-6E48CBC0-DFD7-44B3-BFC5-60785F6A4B1EQ27024533-7C472360-8214-485E-939D-FCF704DCA569Q28297349-BE2CA8ED-949F-4594-ABFD-8569F1FF52ECQ28307030-F8E82C81-E1D5-4B6D-A402-CB59F4389864Q30459324-2D47151D-2CCB-4FD5-A856-8CB332461F2AQ30486741-B53E98D5-7CEC-4A9D-8DE1-ED5EA6AD87A0Q33939940-BE6E6D5A-97D8-4308-8D16-A817E98C6DFCQ33954437-199DA1A6-131E-4B90-BEE2-F4CC01718708Q34068569-B3E0DE95-4E71-45A5-8813-B44B3D7728BDQ34311201-FEFA78E3-DF4D-4361-A235-65DB222E7CD4Q34685643-25DDC371-5997-4CBF-B327-4D7054D7CE94Q35131215-A9A64EB0-35BA-4CF7-8823-6D9ECCE4B50BQ35147284-E2FBCD54-CD22-4E18-B193-22D262FC3B4DQ35507083-591AF07D-E513-4759-88F8-5972962C8830Q35660521-B04212A7-8909-4625-B319-0F427611811CQ35892693-6E3A33C2-E2C5-4D2E-8B3C-F71849D8FAB2Q36767184-A70253E7-F799-4C5D-B8AE-A91BDAD78B88Q37034171-50E7EDC7-899C-4C84-9166-68E3B4824887Q37462824-B3FA74F8-D4E9-490A-9A9B-42C3A2492AB2Q37719826-D2D9C55C-162F-442B-AB8C-2A62A63E7706Q37923872-221B9DD9-6216-41B0-BC1C-DAA9FEFB9F3EQ38023813-3DD79DA1-A537-4A17-B9EC-C45920270A80Q38710668-14FE0BEE-A48A-4636-AD13-96C31824A1BCQ38770267-9A939434-3121-4597-BD24-EBDCF0CDFD0FQ38997913-CBBA2E86-BA31-423F-A6C0-61E6A7C11817Q39036583-D8606B07-B2D0-4DBD-833A-2CCB0307E37CQ42361834-88A5AE3B-1BD1-4947-89DA-7AB206117250Q47609902-D4C3C254-3AEF-44D1-9E45-70CAB6896170Q48348539-4A451B77-0399-49EC-9328-CC472309A075Q50069089-1AFEA20A-FF71-4FED-AF36-73D2ADA3D6A9Q50880973-51556459-4DCF-473B-9C78-6ED2D3C9D0A4
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
GDNF--a potential target to treat addiction.
@en
type
label
GDNF--a potential target to treat addiction.
@en
prefLabel
GDNF--a potential target to treat addiction.
@en
P2860
P1476
GDNF--a potential target to treat addiction.
@en
P2093
Sebastien Carnicella
P2860
P356
10.1016/J.PHARMTHERA.2008.12.001
P577
2008-12-24T00:00:00Z